high dose oral semaglutide In the OASIS 4 phase 3 trial, once-daily at a of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or Ozempic® Pen Dosing | Ozempic®

Comparing Mounjaro to Ozempic at their respective licensed doses gives a different picture than comparing Mounjaro to Wegovy

Mir Ali, MD, board-certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who was not involved in the study, shared his thoughts with MNT : This study confirms what I have seen in other studies comparing the two medications

Clinical trials showed that about 3% of people on the 0.5 mg dose and around 1% of those on the 1 mg dose reported experiencing this side effect

Each comparison reinforces that semaglutide occupies a favorable position in the risk-benefit calculation for cardiovascular impact among weight management medications

There is also the food factor

Some heart conditions that can increase your risk include: Arrhythmias (Irregular Heartbeats): People with atrial fibrillation (AFib) or other rhythm disorders may feel their heartbeat change more often when taking new medications